HPB-092 for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia
Clinical trial NCT07137637 · RECRUITING
Trial details
- NCT number
- NCT07137637
- Sponsor
- Hangzhou Polymed Biopharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-10
- Primary completion
- 2027-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.